相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Risk of Acute Myocardial Infarction Among Patients With Laboratory-Confirmed Invasive Pneumococcal Disease: A Self-Controlled Case Series Study
Andrew D. Wiese et al.
CLINICAL INFECTIOUS DISEASES (2023)
Pneumolysin as a target for new therapies against pneumococcal infections: A systematic review
Maria Dolores Cima Cabal et al.
PLOS ONE (2023)
Acute organ injury and long-term sequelae of severe pneumococcal infections
Katherine L. Kruckow et al.
PNEUMONIA (2023)
Reemergence of Invasive Pneumococcal Disease in Germany During the Spring and Summer of 2021
Stephanie Perniciaro et al.
CLINICAL INFECTIOUS DISEASES (2022)
Pandemic Influenza Infection Promotes Streptococcus pneumoniae Infiltration, Necrotic Damage, and Proteomic Remodeling in the Heart
Maryann P. Platt et al.
MBIO (2022)
Substantial Decline in Invasive Pneumococcal Disease During Coronavirus Disease 2019 Pandemic in Hong Kong
Jade L. L. Teng et al.
CLINICAL INFECTIOUS DISEASES (2022)
Additional effect of azithromycin over β-lactam alone for severe community-acquired pneumonia-associated acute respiratory distress syndrome: a retrospective cohort study
Jun Suzuki et al.
PNEUMONIA (2022)
The Effect of Macrolides on Mortality in Bacteremic Pneumococcal Pneumonia: A Retrospective, Nationwide Cohort Study, Israel, 2009-2017
Michal Chowers et al.
CLINICAL INFECTIOUS DISEASES (2022)
Streptococcus pneumoniae Impairs Maturation of Human Dendritic Cells and Consequent Activation of CD4+ T Cells via Pneumolysin
Antje D. Paulikat et al.
JOURNAL OF INNATE IMMUNITY (2022)
Empirical antibiotic treatment strategies for community-acquired pneumonia: a network meta-analysis
Lu-Yan Xu et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2022)
Pneumolysin suppresses the initial macrophage pro-inflammatory response to Streptococcus pneumoniae
Jimstan Periselneris et al.
IMMUNOLOGY (2022)
Risk of cardiovascular events leading to hospitalisation after Streptococcus pneumoniae infection: a retrospective cohort LIFE Study
Naoaki Nishimura et al.
BMJ OPEN (2022)
Efficacy of erythromycin compared to clarithromycin and azithromycin in adults or adolescents with community-acquired pneumonia: A Systematic Review and meta-analysis of randomized controlled trials
Noha Ashy et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2022)
Protective role of Cav-1 in pneumolysin-induced endothelial barrier dysfunction
Robert K. Batori et al.
FRONTIERS IN IMMUNOLOGY (2022)
Effect of Pneumococcal Vaccine on Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
Vikash Jaiswal et al.
JOURNAL OF CLINICAL MEDICINE (2022)
The remarkable history of pneumococcal vaccination: an ongoing challenge
Daniel M. Musher et al.
PNEUMONIA (2022)
Beta-Lactam Plus Macrolide for Patients Hospitalized With Community-Acquired Pneumonia: Difference Between Autumn and Spring
Yoonjung Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2022)
Major Adverse Cardiovascular Events During Invasive Pneumococcal Disease Are Serotype Dependent
Hector F. Africano et al.
CLINICAL INFECTIOUS DISEASES (2021)
Reversion of Pneumolysin-Induced Executioner Caspase Activation Redirects Cells to Survival
Andreas Nerlich et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Acute cardiovascular events in patients with community acquired pneumonia: results from the observational prospective FADOI-ICECAP study (vol 21, 116, 2021)
Filippo Pieralli et al.
BMC INFECTIOUS DISEASES (2021)
Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development
Jennifer A. Kricker et al.
PHARMACOLOGICAL REVIEWS (2021)
Pneumococal community-acquired pneumonia in the intensive care unit: Azithromycin remains protective despite macrolide resistance
Andrew F. Shorr et al.
RESPIRATORY MEDICINE (2021)
A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant S. pneumoniae in Ambulatory and Hospitalized Adult Patients in the United States
Vikas Gupta et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Neutrophil-Derived Extracellular Vesicles Activate Platelets after Pneumolysin Exposure
Eleftheria Letsiou et al.
CELLS (2021)
Pneumolysin Is Responsible for Differential Gene Expression and Modifications in the Epigenetic Landscape of Primary Monocyte Derived Macrophages
Joby Cole et al.
FRONTIERS IN IMMUNOLOGY (2021)
Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles
Shahan Syed et al.
ISCIENCE (2021)
Clarithromycin Inhibits Pneumolysin Production via Downregulation of ply Gene Transcription despite Autolysis Activation
Hisanori Domon et al.
MICROBIOLOGY SPECTRUM (2021)
The Role of Macrolides for the Management of Community-Acquired Pneumonia and Pneumonia by the Novel Coronavirus SARS-CoV-2 (COVID-19): A Position Paper by Four Medical Societies from Greece
Evangelos J. Giamarellos-Bourboulis et al.
INFECTIOUS DISEASES AND THERAPY (2021)
Burden of Community-Acquired Pneumonia and Unmet Clinical Needs
Joao Ferreira-Coimbra et al.
ADVANCES IN THERAPY (2020)
Endothelial Cell Calcium Signaling during Barrier Function and Inflammation
Prarthana J. Dalal et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Bacterial pore-forming toxin pneumolysin: Cell membrane structure and microvesicle shedding capacity determines differential survival of cell types
Yu Larpin et al.
FASEB JOURNAL (2020)
Cardiovascular Events after Community-Acquired Pneumonia: A Global Perspective with Systematic Review and Meta-Analysis of Observational Studies
Antonio Tralhao et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Treatment of Community-Acquired Pneumonia During the Coronavirus Disease 2019 (COVID-19) Pandemic
Joshua P. Metlay et al.
ANNALS OF INTERNAL MEDICINE (2020)
Pneumolysin: Pathogenesis and Therapeutic Target
Andrew T. Nishimoto et al.
FRONTIERS IN MICROBIOLOGY (2020)
Vascular occlusion by neutrophil extracellular traps in COVID-19
Moritz Leppkes et al.
EBIOMEDICINE (2020)
Inhibition of Necroptosis to Prevent Long-term Cardiac Damage During Pneumococcal Pneumonia and Invasive Disease
Sarah M. Beno et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Mannose receptor-derived peptides neutralize pore-forming toxins and reduce inflammation and development of pneumococcal disease
Karthik Subramanian et al.
EMBO MOLECULAR MEDICINE (2020)
Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19
Coraline Radermecker et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Host- and Pathogen-Related Factors for Acute Cardiac Events in Pneumococcal Pneumonia
Alexander Rombauts et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Macrophage LC3-associated phagocytosis is an immune defense against Streptococcus pneumoniae that diminishes with host aging
Megumi Inomata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Pneumolysin induces platelet destruction, not platelet activation, which can be prevented by immunoglobulin preparations in vitro
Kristin Jahn et al.
BLOOD ADVANCES (2020)
Etiology of community-acquired pneumonia in adults: a systematic review
Saeed Shoar et al.
PNEUMONIA (2020)
Effect of β-Lactam Plus Macrolide Versus Fluoroquinolone on 30-Day Readmissions for Community-Acquired Pneumonia
Travis T. Gilbert et al.
AMERICAN JOURNAL OF THERAPEUTICS (2020)
Respiratory Fluoroquinolones Monotherapy vs. β-Lactams With or Without Macrolides for Hospitalized Community-Acquired Pneumonia Patients: A Meta-Analysis
Sitong Liu et al.
FRONTIERS IN PHARMACOLOGY (2019)
CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial
Pierre-Francois Laterre et al.
LANCET INFECTIOUS DISEASES (2019)
Necroptotic Cell Death Promotes Adaptive Immunity Against Colonizing Pneumococci
Ashleigh Nichole Riegler et al.
FRONTIERS IN IMMUNOLOGY (2019)
Diagnosis and Treatment of Adults with Community-acquired Pneumonia An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
Joshua P. Metlay et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Macrolide combination therapy for patients hospitalised with community-acquired pneumonia? An individualised approach supported by machine learning
Rainer Koenig et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Platelet Biogenesis in the Lung Circulation
Emma Lefrancais et al.
PHYSIOLOGY (2019)
A Hypothesis-Generating Study of the Combination of Aspirin plus Macrolides in Patients with Severe Community-Acquired Pneumonia
Marco Falcone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia
Adrian Ceccato et al.
CHEST (2019)
Outcomes of Macrolide Deescalation in Severe Community-acquired Pneumonia
Tiffany M. Hopkins et al.
CLINICAL THERAPEUTICS (2019)
Pathogenesis and prevention of risk of cardiovascular events in patients with pneumococcal community-acquired pneumonia
C. Feldman et al.
JOURNAL OF INTERNAL MEDICINE (2019)
Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival
Karthik Subramanian et al.
NATURE MICROBIOLOGY (2019)
Azithromycin combination therapy for community-acquired pneumonia: propensity score analysis
Akihiro Ito et al.
SCIENTIFIC REPORTS (2019)
Platelet-Neutrophil Interplay: Insights Into Neutrophil Extracellular Trap (NET)-Driven Coagulation in Infection
Amanda Z. Zucoloto et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2019)
Empiric antibiotics for community-acquired pneumonia: A macrolide and a beta-lactam please!
Grant Waterer
RESPIROLOGY (2018)
The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: results from the community-acquired pneumonia organization
Paula Peyrani et al.
INFECTIOUS DISEASES (2018)
Ceftriaxone combination therapy versus respiratory fluoroquinolone monotherapy for community-acquired pneumonia: A meta-analysis
Ying-Qi Zhang et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2018)
Prognostic and Pathogenic Role of Angiopoietin-1 and-2 in Pneumonia
Birgitt Gutbier et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired Pneumonia
Ronald Anderson et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Necroptosis: a regulated inflammatory mode of cell death
Yogesh K. Dhuriya et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Mechanism of Macrolide-Induced Inhibition of Pneumolysin Release Involves Impairment of Autolysin Release in Macrolide-Resistant Streptococcus pneumoniae
Hisanori Domon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Severity and properties of cardiac damage caused by Streptococcus pneumoniae are strain dependent
Anukul T. Shenoy et al.
PLOS ONE (2018)
Moving Past the Routine Use of MacrolidesReviewing the Role of Combination Therapy in Community-Acquired Pneumonia
Geoffrey Shumilak et al.
CURRENT INFECTIOUS DISEASE REPORTS (2018)
Human alveolar macrophages predominately express combined classical M1 and M2 surface markers in steady state
Elena Mitsi et al.
RESPIRATORY RESEARCH (2018)
Beneficial Effects of Vaccination on Cardiovascular Events: Myocardial Infarction, Stroke, Heart Failure
Katerina Fountoulaki et al.
CARDIOLOGY (2018)
Pneumolysin mediates heterotypic aggregation of neutrophils and platelets in vitro
Jan G. Nel et al.
JOURNAL OF INFECTION (2017)
Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis
Jong Hoo Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2017)
The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors
Emma Lefrancais et al.
NATURE (2017)
Streptococcus pneumoniae in the heart subvert the host response through biofilm-mediated resident macrophage killing
Anukul T. Shenoy et al.
PLOS PATHOGENS (2017)
Cardiovascular complications in patients with sickle cell disease
Mark T. Gladwin
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2017)
Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus
Daniel M. Musher et al.
CLINICAL INFECTIOUS DISEASES (2017)
Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling
Luis F. Reyes et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Pore-forming toxin-mediated ion dysregulation leads to death receptor-independent necroptosis of lung epithelial cells during bacterial pneumonia
Norberto Gonzalez-Juarbe et al.
CELL DEATH AND DIFFERENTIATION (2017)
Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice
Braedon McDonald et al.
BLOOD (2017)
Pneumolysin activates neutrophil extracellular trap formation
J. G. Nel et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Infiltrated Macrophages Die of Pneumolysin-Mediated Necroptosis following Pneumococcal Myocardial Invasion
Ryan P. Gilley et al.
INFECTION AND IMMUNITY (2016)
Pneumolysin Mediates Platelet Activation In Vitro
Jan Gert Nel et al.
LUNG (2016)
Capsules of virulent pneumococcal serotypes enhance formation of neutrophil extracellular traps during in vivo pathogenesis of pneumonia
Anandi Narayana Moorthy et al.
ONCOTARGET (2016)
Macrolide-Resistant Pneumococcus in Community-acquired Pneumonia Is There Still a Role for Macrolide Therapy?
Michael S. Niederman
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Cardiotoxicity during Invasive Pneumococcal Disease
Armand O. Brown et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized for Streptococcus pneumoniae Pneumonia
Catia Cilloniz et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Ca2+-dependent repair of pneumolysin pores: A new paradigm for host cellular defense against bacterial pore-forming toxins
Heidi Wolfmeier et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Streptococcus pneumoniae Translocates into the Myocardium and Forms Unique Microlesions That Disrupt Cardiac Function
Armand O. Brown et al.
PLOS PATHOGENS (2014)
Characterization of recombinant Streptococcus mitis-derived human platelet aggregation factor
Hisashi Ohkuni et al.
APMIS (2012)
Cardiac Complications in Patients With Community-Acquired Pneumonia Incidence, Timing, Risk Factors, and Association With Short-Term Mortality
Vicente F. Corrales-Medina et al.
CIRCULATION (2012)
Export Requirements of Pneumolysin in Streptococcus pneumoniae
Katherine E. Price et al.
JOURNAL OF BACTERIOLOGY (2012)
The Complex Role of Angiopoietin-2 in the Angiopoietin-Tie Signaling Pathway
Gavin Thurston et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin
Alexandros B. Tsoupras et al.
JOURNAL OF INFLAMMATION-LONDON (2011)
Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease
Jason W. Rosch et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Pneumolysin Localizes to the Cell Wall of Streptococcus pneumoniae
Katherine E. Price et al.
JOURNAL OF BACTERIOLOGY (2009)
Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro
R. Anderson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
The association between pneumococcal pneumonia and acute cardiac events
Daniel M. Musher et al.
CLINICAL INFECTIOUS DISEASES (2007)
Role of platelet-activating factor in pneumolysin-induced acute lung injury
Martin Witzenrath et al.
CRITICAL CARE MEDICINE (2007)
Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae
R. Anderson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia
M Witzenrath et al.
CRITICAL CARE MEDICINE (2006)
Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae
Y Fukuda et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults
J Korsgaard et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2005)
Macrolides and ketolides: azithromycin, clarithromycin, telithromycin
JM Zuckerman
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2004)
Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type
A Kadioglu et al.
INFECTION AND IMMUNITY (2002)
Proinflammatory interactions of pneumolysin with human neutrophils
R Cockeran et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Subinhibitory concentrations of erythromycin reduce pneumococcal adherence to respiratory epithelial cells in vitro
K Lagrou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Staphylococcal α-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts -: Role of thromboxane generation
U Sibelius et al.
CIRCULATION (2000)